1153 CYCLOPHILIN INHIBITOR ALISPORIVIR (ALV) COMBINATIONS WITH DIRECT ACTING ANTIVIRALS REVEAL STRONG SYNERGISTIC ANTI-HCV EFFECTS

Javier García-Rivera(Scripps Research Institute), Philippe Gallay(Scripps Research Institute), Udayan Chatterji(Scripps Research Institute)
Journal of Hepatology
April 1, 2013
Cited by 3


Related Papers